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of viral infections are highlighted, using examples of well-
studied virus infections that are associated with these altera-
tions in different populations throughout the world. A better 
understanding of the molecular, epidemiological and bio-
logical characteristics of these infections and in particular of 
mechanisms that underlie their clinical manifestations may be 
expected to provide tools for the development of more effec-
tive intervention strategies and treatment regimens.
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Abstract A wide range of viruses from different virus fami-
lies in different geographical areas, may cause immediate or 
delayed neuropathological changes and neurological mani-
festations in humans and animals. Infection by neurotropic 
viruses as well as the resulting immune response can irrevers-
ibly disrupt the complex structural and functional architecture 
of the central nervous system, frequently leaving the patient 
or affected animal with a poor or fatal prognosis. Mechanisms 
that govern neuropathogenesis and immunopathogenesis 
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Introduction
Neurotropic virus infections continue to cause major dis-
ease and economic burdens on society, and pose a major 
challenge to human and animal health care systems due to 
the associated morbidity and mortality worldwide, and to 
the unique problems in providing treatment to the patients 
involved. This is largely due to unique features of the cen-
tral nervous system (CNS), with a plethora of interconnected 
and interdependent cell types, complex structures and func-
tions, reduced immune surveillance and limited regeneration 
capacity. Infection by neurotropic viruses as well as the local 
induced immune responses can irreversibly disrupt the com-
plex structural and functional architecture of the CNS, fre-
quently leaving the patient or affected animal with a poor or 
fatal prognosis. Besides immediate and direct effects, there 
are several neurological disorders often associated with auto-
immune mechanisms that are assumed to be delayed virus-
induced disorders: multiple sclerosis, Guillain–Barré syn-
drome, narcolepsy and encephalitis lethargica. Neurotropic 
pathogens can access the brain by various routes including 
retrograde axonal transport along motor and olfactory neu-
rons, haematogenous spread across the blood–brain barrier 
(BBB), blood–cerebrospinal fluid barrier, meningeal–cer-
ebrospinal fluid barrier, via direct infection of endothelial 
cells or via spread of infected leukocytes across the BBB 
into the brain parenchyma (Fig. 1). There is an unmet need 
to understand mechanisms that lead to neuropathological or 
immunopathological alterations occurring after the virus has 
entered the CNS or other parts of the body and the clinical 
manifestations that are associated with these changes. Fur-
thermore, more insights into the molecular, epidemiologi-
cal and biological characteristics of viral CNS infections are 
needed. Collectively, this will provide tools for the develop-
ment of more effective intervention and antiviral treatment 
regimens. This development will be aided by the juxtaposi-
tion of increasingly sophisticated technologies, like those 
coming from the emerging fields of virus reverse genetics, 
brain imaging and advanced cellular phenotyping. This 
review aims to provide an updated overview of the different 
mechanisms involved in the pathogenesis of viral CNS infec-
tions, using clear examples of well-studied virus infections 
(Table 1), rather than by providing an exhaustive overview 
of the knowledge of all neurotropic viruses. For this reason 
we have not included any discussion of lentiviruses, many of 
which are also capable of infecting the CNS.
Alphaviruses
The genus Alphavirus of the Togaviridae family comprises 
a group of enveloped, single-strand positive-sense RNA 
viruses, most of which are transmitted by mosquitoes. 
Typically, human infections with old-world alphaviruses 
such as O’nyong-nyong and Ross River virus manifest 
as fever, maculopapular rash and polyarthritis, whereas 
infection with the new-world equine encephalitis viruses 
(EEVs) can result in potentially fatal encephalitis. Enceph-
alitic alphaviruses of public health concern include the 
new-world alphaviruses Eastern equine encephalitis virus 
(EEEV), Venezuelan equine encephalitis viruses (VEEV) 
and Western equine encephalitis virus (WEEV). More 
recently, the old-world Chikungunya virus (CHIKV) was 
also associated with encephalitis. Considering that WEEV 
cases have become infrequent and sporadic, this chapter 
focuses on neurologic manifestations of EEEV, VEEV and 
CHIKV infections.
EEEV is enzootic to the eastern United States, the 
Great Lakes region and the Gulf Coast where it circulates 
between birds and the ornithophilic mosquito Culiseta 
melanura. Several Aedes, Coquillettidia and Culex mos-
quitoes function as bridge vectors, transmitting the virus to 
equines and humans, which can suffer from severe disease. 
The related VEE viruses circulate in Central and South 
America. These viruses are grouped into six antigenic sub-
types (I–VI). Human epidemics and equine epizootics are 
almost exclusively caused by viruses of antigenic variants 
A/B and C of subtype I. The remaining antigenic variants 
circulate in enzootic sylvatic cycles between rodents and 
Culex (Melanoconion) mosquitoes. Subtypes I A/B and C, 
which are highly virulent for horses, are believed to result 
from adaptation of enzootic strains to equines (horses, 
donkeys and mules). This adaptation allows the virus to 
replicate to extremely high levels, resulting in 20–80 % 
mortality [100]. Aedes (Ochlerotatus) taeniorhynchus is 
considered the major bridge vector of epidemic/epizootic 
strains. The geographic distribution of CHIKV includes 
sub-Saharan Africa, India, Southeast Asia, the Western 
Pacific with recent spread to the Caribbean and South 
America. The virus circulates in a sylvatic cycle between 
nonhuman primates and forest-dwelling Aedes mosqui-
toes. In the urban cycle, Aedes aegypti and Aedes albop-
ictus mosquitoes are responsible for virus transmission to 
humans.
Eastern equine encephalitis virus
EEEV infections in humans can manifest as two forms of 
disease: systemic or encephalitic. Systemic disease pre-
sents after an incubation period of 4–10 days as fever, 
malaise, muscle and joint pains and resolves without 
treatment within 1–2 weeks. The encephalitic form has 
an abrupt onset in infants, whereas in older patients neu-
rological signs are observed a few days after onset of 
systemic disease. Patients may develop severe headache, 
confusion, neck stiffness, seizures, a decline in the level 
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Fig. 1  Routes of virus spread into the central nervous system. a 
Infection of peripheral nerves. (i) Virus spread from mucosal epithe-
lium (ME) to sensory and autonomic neurons (SN) following infec-
tion of axon termini. Retrograde axonal transport results in virus 
spread to the spinal cord (SC). (ii) Virus infection of motor neurons 
(MN) at neuromuscular junctions in smooth muscle (SM) results in 
retrograde axonal transport to the spinal cord and the brain. b Blood–
brain barrier (BBB). Virus-infected lymphocytes (green) (1) in blood 
vessels (BV) ‘roll’ along the endothelium (2), attach to the endothelial 
cells (3) and transverse the endothelial cell layer (EC) (4) and the glia 
limitans (GL). Virus spread to neurons (5) is assumed to occur fol-
lowing contacts with uninfected neurons. Alternatively, direct virus 
infection of endothelial cells may occur with subsequent spread into 
the brain parenchyma resulting in neuronal infection. c Infection 
of olfactory neurons. Virus present in the mucosa (M) of the upper 
respiratory tract can directly infect olfactory sensory neurons (OSN) 
present in olfactory epithelium (OE). Anterograde axonal transport 
leads to spread of virus within axonal bundles passing through the 
cribriform plate (CP) into the olfactory bulb (OB). Trans-synaptic 
spread to mitral cells (MC) results in virus spread along the olfactory 
tract (OT) to other brain regions. d Meningeal blood–cerebrospinal 
fluid (CSF) barrier. Virus-infected leukocytes in meningeal blood 
vessels present within the sub-arachnoid space between the pia and 
arachnoid roll, attach to the endothelium and transverse endothe-
lial cells into the CSF. Direct infection of endothelial cells may also 
lead to virus spread into the CSF. e Blood–cerebrospinal fluid bar-
rier. Virus-infected leukocytes or cell-free virus present within blood 
vessels of the choroid plexus (CHP) transverse the endothelium as 
described previously in b, d. This can lead to infection of epithelial 
cells and apical release of virus or spread of virus-infected leukocytes 
across the CHP epithelium into the CSF. Figure was composed using 
©Motifolio.com Biomedical PowerPoint Toolkit Suite
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of consciousness and coma. Infection with the highly viru-
lent North American (NA) EEEV strains can lead to a case 
fatality ratio of up to 40 %, which makes NA-EEEV the 
most deadly encephalitic alphavirus. Patients that survive 
the infection may suffer from serious sequelae such as 
mental retardation and paralysis.
Gross pathological examinations of human cases have 
revealed diffuse cerebral edema, vascular congestion and 
occasionally hemorrhages. Due to the hematogenous 
route of infection in the acute stage of the disease, a pre-
dominant panencephalitis and meningitis with vasculi-
tis, occasional thrombosis and perivascular to widespread 
edema are found. Neuronophagia, microglial nodules and 
lympho-histiocytic, predominantly perivascular infiltra-
tions are encountered in various regions of the brain. How-
ever, a predilection of damage exists for basal ganglia and 
brain stem. Alterations to the spinal cord are very limited 
with occasional lesions in the upper cervical region [28, 
74, 117]. Neurons appeared to be the major target cells 
although infection of glial cells has been reported [41].
Venezuelan equine encephalitis virus
Symptoms of VEEV infection generally manifest 2–5 days 
after a mosquito bite. Symptoms of VEEV infection 
include fever with chills, severe retro-orbital and occipital 
headache, nausea with vomiting, sore throat, diarrhea, tach-
ycardia and myalgia; typically centering in the thighs and 
lumbar region of the back [139]. Children are more suscep-
tible to severe disease than adults and are more likely to 
suffer from permanent neurological sequelae. Neurological 
complications include confusion, somnolence, delirium, 
nuchal rigidity, spastic paralysis, ataxia and photophobia. 
Less common symptoms include tremors, paralysis, nys-
tagmus, pathological reflexes, cranial nerve palsies, syn-
drome of inappropriate antidiuretic hormone (SIADH) 
secretion, visual defects and coma. Lethal outcomes are 
associated with diffuse edema, brain hemorrhage, hepato-
cellular degeneration, alveolar hemorrhage and interstitial 
pneumonia [27, 62]. Although the overall case fatality ratio 
of VEE is below 1 %, its association with outbreaks involv-
ing tens of thousands of human cases renders it the most 
important encephalitic alphavirus.
Histopathology studies on autopsied patients have iden-
tified spleen, lymph nodes, intestinal lymphoid tissues, 
liver, lungs and the CNS as the principle target organs of 
VEEV. Moderate to marked diffuse congestion and edema 
with hemorrhage can be observed in brain, gastrointestinal 
tract and lungs. Mild or focal mixed inflammatory cell infil-
trates can be detected in the leptomeninges and perivascu-
lar spaces. Depletion of lymphocytes with vascular throm-
bosis and necrosis of follicles can be observed in lymph 
nodes, spleen and gastrointestinal tract. Hepatocellular 
degeneration with necrosis of individual cells is observed in 
the majority of cases. A high percentage of individuals may 
present interstitial pneumonia. Although the major target 
cells of VEEV in humans have yet to be identified, patho-
logical findings have suggested that hepatocytes, vascular 
endothelial cells, B cells, and cortical neurons are affected 
during the course of the disease. Importantly, lesions were 
proposed to result from direct injury or immune-mediated 
clearance of infected cells [27].
Chikungunya virus
After an incubation period of typically 3–7 days, CHIKV 
infection manifests with high fever, headache, maculopapu-
lar rash and painful arthralgia. Other symptoms include 
retro-orbital pain, myocarditis and hemorrhage. Most 
patients recover within 1–2 weeks, but joint pain may per-
sist for several months to years. Sporadic CHIKV neuro-
logical manifestations have been described since the 1960s 
and 1970s, but cases were not well documented. More 
recently, a series of serious outbreaks occurred in countries 
with modern clinical facilities that facilitated more detailed 
studies leading to novel insights into CHIKV-mediated 
neurological disease. During the well-documented out-
break in 2005–2006 on Réunion Island, neurological signs 
were reported in 12 % of patients [14]. In children and 
adults, neurological manifestations include altered levels 
of consciousness, cranial nerve deficits, seizures, decreased 
deep tendon reflexes, psychosis, hemi/paraparesis, para-
plegia and involuntary movements. A subset of children 
of <1 year presented with hypotonia, tense fontanelle and 
status epilepticus [10]. Apart from mosquito-transmitted 
infection, CHIKV can be transmitted from viremic mother 
to child during birth. Although rare, these infections result 
in severe encephalopathy in almost half of the cases. Mani-
festations include brain swelling, disseminated intravascu-
lar coagulation, cerebral or cerebellar hemorrhage, scat-
tered parenchymal petechiae, cerebellar hematoma and 
hematemesis [43]. Brain lesions comprise edema with focal 
ischemic changes in the frontal and occipital cortexes and 
the internal capsule, as well as hemorrhages, demyelination 
and cavitations located in the periventricular subcortical 
white matter. Minimal microgliosis may occur in the corti-
cal gray matter and diencephalon with occasional perivas-
cular lymphocytic infiltrates noted [40]. The changes seem 
to result from transient ischemia with cytotoxic edema and 
not from neuronal death.
Bornaviridae
Bornaviruses belong to the family Bornaviridae, of 
the order Mononegavirales and are single-stranded 
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negative-sensed RNA viruses. These viruses display a 
number of unique features that are not typical for non-
segmented negative-sense RNA viruses such as nuclear 
transcription and replication and their ability to establish a 
non-cytolytic persistent CNS infection. The classical mam-
malian Bornavirus BoDV-1 (Borna disease virus, BDV), 
the prototype of this family, causes a typically fatal neuro-
logical disease (Borna disease, BD) in horses and sheep in 
endemic areas of central Europe with an incubation period 
of 2–4 months before the onset of clinical neurological 
signs of infection (reviewed in [55]). However, in experi-
mental settings, the host range is much wider, ranging from 
chickens to primates. Serological studies have shown that 
the distribution of Bornaviruses might be widespread, pos-
sibly worldwide. However, clinical BD accumulates in geo-
graphically restricted endemic areas, suggesting the exist-
ence of a natural reservoir. In accordance to this, infectious 
BoDV-1 was detected in tissues of white-toothed shrews 
(Crocidura leucodon) in endemic areas of Germany and 
Switzerland [15, 56].
BoDV-1 was considered the only member of the family 
Bornaviridae until the last decade. Since then, knowledge 
on Bornaviruses has expanded tremendously. Endogenous 
genome-integrated Bornavirus-like sequences have been 
detected in various vertebrate species, including snakes, 
bats, elephants, fish, lemurs, rodents, squirrels, primates 
and humans [38, 59]. Moreover, new genetically dis-
tant Bornaviruses have been detected in many other spe-
cies, including psittacine birds, water fowl, and reptiles 
by means of next-generation sequencing [58, 67]. A novel 
Bornavirus, recently discovered in variegated squirrels 
(variegated squirrel Borna virus-1; VSBV-1), was associ-
ated with three human cases of fatal encephalitis indicat-
ing its zoonotic potential [57]. In contrast, the serological 
and virological data for human infections by BoDV-1 are 
more uncertain. BoDV-1-specific antibodies can be present 
in sera of patients with various psychiatric conditions but 
also in clinically healthy people. There is general consen-
sus that BoDV-1 is not associated with human psychiatric 
illness [34, 60]. It should be emphasized that the human 
VSBV-1 infections (encephalitis) are quite different from 
previous studies dealing with potential human BoDV-1 
infections [57]. The incubation period of VSBV-1 or poten-
tially BoDV-1 in humans is unknown.
In the natural host, Crocidura leucodon, BoDV-1 dis-
seminates to both neural and extra-neural tissues and is 
continuously shed via secretions, excretions and skin scal-
ing [15, 92]. In contrast, BoDV-1 infection is strictly neu-
rotropic in dead-end hosts, in which it causes a severe 
non-purulent meningoencephalitis. The newly detected 
VSBV-1 was also found in many organs including the CNS 
in a contact squirrel and brain of diseased squirrel breeders 
(Fig. 2a) who also presented with non-purulent (meningo-) 
encephalitis [57]. Patients suffered from shivers, fever, 
confusion, psychomotor and gait disturbances and finally 
coma. All of them had underlying medical conditions such 
as hypertension, diabetes or obesity. Infection of horses 
with BoDV-1 may manifest as excited or depressed behav-
ior, abnormal posture and movement and may result in a 
mortality rate of up to 90 %. However, in the majority of 
equine cases, BoDV-1 infections are clinically inappar-
ent and are associated with long-lasting specific serum 
antibodies.
Experimental Bornavirus infections have provided evi-
dence for intranasal virus transmission via olfactory nerve 
endings with retrograde transaxonal spread to the olfactory 
bulb and subsequently the brain. Primary target cells are 
neurons and astrocytes, but oligodendrocytes and ependy-
mal cells can also be infected. Pathogenesis is best studied 
in the rat model where remarkable differences in clinical 
course and virus distribution occur depending on the state of 
the immune system and time point of infection (reviewed in 
Fig. 2  Immunohistochemcial detection of the X-protein of novel 
Bornavirus (variegated squirrel Borna virus-1; VSBV-1) in human 
brain sections (a) and demonstration of Borna disease virus 1 (BoDV-
1) X-protein in the hippocampus of a horse which had neurologi-
cal signs of BoDV-1 infection (b). Viral X-protein is present in the 
nuclei, cytoplasm and cellular processes of infected neurons
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[55]). Infection of newborn immunocompetent rats results 
in a persistent CNS infection with virus spread to periph-
eral organs with no obvious neurological signs. However, 
disturbances in learning and memory and loss of distinct 
hippocampal and cerebellar neurons are observed. In adult 
rats, virus infection is also persistent but it is restricted to 
the CNS and associated with a severe non-purulent menin-
goencephalitis and biphasic neurologic disease comparable 
to clinical signs observed in humans and equines. In horses 
and rats, the characteristic histological picture consists of 
extensive mononuclear perivascular cuffing, astroglial and 
microglial activation and eosinophilic intranuclear inclu-
sions in neurons, called “Joest–Degen” bodies with viral 
antigen detected in immunohistochemically stained brain 
sections (Fig. 2b). In VSBV-1-infected patients, compara-
ble lesions develop with edema, necrosis, glial activation, 
and lymphocytic, often perivascular infiltrates. In animals, 
gray matter areas are predominantly affected, e.g., cer-
ebral cortex, caudate nucleus, thalamus and hippocampus. 
Experimental BoDV-1 infection of rodents implicates a 
pivotal role of immunopathogenic CD4 and CD8 T cells 
(reviewed in [55]). Thus, infection does not cause a protec-
tive immune response and virus-specific antibodies typi-
cally lack virus-neutralizing capacity.
Bunyaviridae
The family Bunyaviridae comprises over 350 named 
viruses, most of which are transmitted by insects or ticks. 
Bunyaviruses are enveloped, spherical particles of about 
100 nm in diameter, containing a three-segmented negative-
strand RNA genome. The Orthobunyavirus and Phlebovi-
rus genera include members that are associated with human 
CNS disease. The Orthobunyavirus genus is the largest 
of the Bunyaviridae family, comprising more than 170 
viruses. Important human pathogens include Oropouche 
virus, Ngari virus and La Crosse virus (LACV); whereas 
the former two are associated with acute, self-limiting 
febrile illness or hemorrhagic fever, respectively, LACV is 
associated with neurological disease and is the major cause 
of arboviral (arthropod-borne virus) neuroinvasive disease 
in the United States. LACV is present throughout the mid-
western and eastern United States and is also emerging in 
Appalachia, where it circulates between the primary mos-
quito vector Aedes (Ochleratatus) triseriatus (eastern tree-
hole mosquito) and small mammals, mostly chipmunks and 
tree squirrels. A member of the phlebovirus genus associ-
ated with encephalitis is Rift Valley fever virus (RVFV). 
RVFV is transmitted by Aedine, Culicine and Anopheline 
mosquitoes among mammals, of which domesticated rumi-
nants are the most susceptible to disease. Currently, the 
virus is largely confined to the African continent, but global 
distribution of potential mosquito vectors explains the 
fear for future “virgin soil” epizootics and epidemics. The 
sandfly-transmitted Phlebovirus, Toscana virus (TOSV), is 
associated with neurological disease and is a major cause 
of acute, generally mild aseptic meningitis in the Mediter-
ranean region. In these areas, the virus is transmitted by 
Phlebotomus perniciosus and Phlebotomus perfiliewi flies.
La Crosse virus
Symptoms resulting from LACV infection develop after an 
incubation period of 5–15 days. Like most arbovirus infec-
tions, LACV infections are generally subclinical or present 
as a self-limiting febrile disease with headache, fever, nau-
sea and vomiting with minimal neurological involvement. 
Children under 15 years of age are at risk of developing 
severe neurological disease, which may resemble herpes 
simplex virus (HSV) encephalitis, particularly when focal 
signs are present [79, 148]. Red blood cells and increases 
in protein concentrations may be detected in cerebrospinal 
fluid (CSF), although not as pronounced as in HSV enceph-
alitis. Symptoms include focal neurological signs, photo-
phobia, decreased alertness, drowsiness, neck stiffness and 
disorientation. Up to 50 % of hospitalized patients develop 
seizures. Case fatality rate among symptomatic cases is 
below 1 %, whereas a high case fatality rate of 3.1 % was 
recorded in West Virginia [50]. Pathology in humans is 
believed to result from infection, dysfunction and death of 
neurons, although in vitro studies demonstrated that LACV 
infection does not result in apoptosis of postmitotic human 
neurons [97]. The role of neurons in LACV pathogenesis 
as well as those of additional target cells thus remains to 
be elucidated. Children are predisposed to LACV-induced 
CNS manifestation and may develop cerebral edema with 
increase of intracranial pressure. Morphological changes 
comprise lymphocytic leptomeningitis and perivascular 
cuffs, occasional foci of necrosis, predominantly in the cer-
ebral cortex and brain stem [74].
Rift Valley fever virus
Human RVFV infections result from mosquito bites or con-
tact with contaminated animal products. Most infections 
manifest typically after 2–6 days as a self-limited, benign 
illness with flu-like symptoms. In <1 % of cases, severe 
complications may develop including fulminant hepatitis, 
renal failure, retinopathy resulting in temporary or perma-
nent blindness, hemorrhagic fever and encephalitis. The lat-
ter presents 1–4 weeks after onset of initial symptoms. The 
first fatal RVF cases, associated with hemorrhagic fever 
and encephalitis, occurred in South Africa in 1975 [134]. 
Encephalitis cases occurred during all major subsequent 
RVF outbreaks, although the incidence among hospitalized 
Acta Neuropathol 
1 3
Ta
bl
e 
1 
 S
um
m
ar
y 
of
 v
ir
us
-i
nd
uc
ed
 n
eu
ro
lo
gi
ca
l d
is
or
de
rs
, d
ia
gn
os
tic
, t
he
ra
py
, p
at
ho
lo
gy
 a
nd
 v
ir
us
-s
pe
ci
fic
 fi
nd
in
gs
 in
 h
um
an
s
A
C
V
 a
cy
cl
ov
ir
, A
G
M
 A
fr
ic
an
 g
re
en
 m
on
ke
y,
 C
H
IK
 C
hi
ku
ng
un
ya
, C
M
V
 c
yt
om
eg
al
ov
ir
us
, C
SF
 c
er
eb
ro
sp
in
al
 fl
ui
d,
 d
sD
N
A
, D
FA
 d
ir
ec
t fl
uo
re
sc
en
t a
nt
ig
en
; d
ou
bl
e-
st
ra
nd
ed
 D
N
A
, E
B
V
 E
ps
te
in
–
B
ar
r 
vi
ru
s,
 E
E
E
 E
as
te
rn
 E
qu
in
e 
en
ce
ph
al
iti
s,
 G
C
V
 g
an
ci
cl
ov
ir
, F
C
 f
os
ca
rn
et
, H
SV
 h
er
pe
s 
si
m
pl
ex
 v
ir
us
, H
eV
 H
en
dr
a 
vi
ru
s,
 H
H
V
6 
hu
m
an
 h
er
pe
sv
ir
us
 6
, H
R
IG
 h
um
an
 r
ab
ie
s 
im
m
un
og
lo
bu
lin
, 
IP
 im
m
un
op
at
ho
lo
gy
, I
V
IG
 in
tr
av
en
ou
s 
im
m
un
og
lo
bu
lin
, L
A
C
V
 L
a 
C
ro
ss
e 
vi
ru
s,
 M
V
 m
ea
sl
es
 v
ir
us
, M
uV
 m
um
ps
 v
ir
us
, N
iV
 N
ip
ah
 v
ir
us
, q
P
C
R
 q
ua
nt
ita
tiv
e 
PC
R
, R
V
F
V
 R
if
t V
al
le
y 
fe
ve
r 
vi
ru
s,
 
R
T-
P
C
R
 r
ev
er
se
 tr
an
sc
ri
pt
io
n 
po
ly
m
er
as
e 
ch
ai
n 
re
ac
tio
n,
 R
T-
qP
C
R
 r
ev
er
se
 tr
an
sc
ri
pt
io
n 
qu
an
tit
at
iv
e 
PC
R
, (
+)
 s
s 
po
si
tiv
e-
se
ns
ed
 s
in
gl
e-
st
ra
nd
, (
−)
 s
s 
ne
ga
tiv
e-
se
ns
ed
 s
in
gl
e-
st
ra
nd
, T
O
SV
 T
os
-
ca
na
 v
ir
us
, t
s 
th
re
e-
se
gm
en
te
d,
 V
E
E
 V
en
ez
ue
la
n 
eq
ui
ne
 e
nc
ep
ha
lit
is
, V
I 
vi
ru
s-
in
du
ce
d,
 V
SB
V
-1
 v
ar
ie
ga
te
d 
sq
ui
rr
el
 1
 b
or
na
vi
ru
s,
 V
Z
V
 v
ar
ic
el
la
 z
os
te
r 
vi
ru
s
A
lp
ha
vi
ru
se
s 
B
un
ya
-
vi
ru
se
s
B
or
na
vi
ru
se
s 
(V
SB
V
-1
)
Fl
av
iv
ir
us
es
H
er
pe
sv
ir
us
es
In
flu
en
za
 v
ir
us
Pi
co
rn
av
ir
us
es
Pa
ra
m
yx
ov
ir
us
es
R
ha
bd
ov
ir
us
es
V
ir
us
 c
ha
ra
ct
er
-
is
tic
s
(+
) 
ss
 R
N
A
 
(a
lp
ha
vi
ru
s)
(−
) 
ts
 R
N
A
 (
bu
n-
ya
vi
ru
s)
(−
) 
ss
 R
N
A
(+
) 
ss
 R
N
A
L
ar
ge
 e
nv
el
op
ed
 
ds
D
N
A
Se
gm
en
te
d
(−
) 
ss
 R
N
A
(+
) 
ss
 R
N
A
N
on
-s
eg
m
en
te
d
(−
) 
ss
 R
N
A
N
on
-s
eg
m
en
te
d
(−
) 
ss
 R
N
A
C
lin
ic
al
 p
re
se
nt
a-
tio
n
E
nc
ep
ha
lit
is
, m
en
-
in
gi
tis
, h
em
or
-
rh
ag
ic
 m
an
if
es
ta
-
tio
ns
E
nc
ep
ha
lit
is
, m
yo
-
cl
on
us
, o
cu
la
r 
pa
re
si
s
E
nc
ep
ha
lit
is
, m
en
-
in
gi
tis
,
E
nc
ep
ha
lit
is
, M
en
-
in
gi
tis
, m
ye
lit
is
, 
po
ly
ra
di
cu
lit
is
 
an
d 
ne
ur
op
at
hi
es
A
cu
te
: v
ar
ie
s 
fr
om
 s
ei
zu
re
s 
to
 e
nc
ep
ha
lit
is
/
en
ce
ph
al
op
at
hy
In
 u
te
ro
: p
sy
ch
ia
tr
ic
 
di
so
rd
er
s
M
en
in
gi
tis
, 
en
ce
ph
al
iti
s,
 
po
lio
m
ye
lit
is
E
nc
ep
ha
lit
is
, m
en
-
in
gi
tis
E
nc
ep
ha
lit
is
, d
ys
au
-
to
no
m
ia
D
ia
gn
os
is
C
lin
ic
al
 p
ic
tu
re
 a
nd
 
Ig
M
 d
et
ec
tio
n
M
et
ag
en
om
ic
 
an
al
ys
is
, R
T-
qP
C
R
Ig
M
 in
 C
SF
 o
r 
se
ru
m
 n
eu
ro
im
-
ag
in
g
C
lin
ic
al
 p
ic
tu
re
, 
ne
ur
oi
m
ag
in
g 
an
d 
qP
C
R
 o
f 
C
SF
C
lin
ic
al
 p
ic
tu
re
, 
qP
C
R
 o
f 
C
SF
 o
r 
po
st
-m
or
te
m
 C
N
S 
tis
su
es
R
T-
PC
R
 C
SF
, s
to
ol
, 
th
ro
at
C
lin
ic
al
 p
ic
tu
re
, 
ne
ur
oi
m
ag
in
g,
 
Ig
G
 d
et
ec
tio
n,
 
R
T-
PC
R
 C
SF
C
lin
ic
al
 p
ic
tu
re
R
T-
PC
R
, D
FA
 
de
te
ct
io
n
Pa
th
ol
og
y
V
I
IP
V
I 
an
d 
IP
V
I:
 H
SV
 a
nd
 V
Z
V
IP
: C
M
V
, E
B
V
 a
nd
 
H
H
V
6
V
I 
an
d 
IP
V
I
V
I:
 M
V
, M
uV
, 
N
iV
, H
eV
IP
: M
V
V
I
Sp
ec
ifi
cs
R
is
k 
of
 s
us
ta
in
ed
 
ne
ur
ol
og
ic
al
 
se
qu
el
ae
Fa
ta
l o
ut
co
m
e;
 
zo
on
ot
ic
 in
fe
c-
tio
n
Pa
tie
nt
 a
ge
 c
an
 
af
fe
ct
 p
ro
gn
os
is
R
is
k 
of
 n
eu
ro
ps
y-
ch
ia
tr
ic
 s
eq
ue
la
e
R
is
k 
fa
ct
or
 f
or
 
di
se
as
es
 s
uc
h 
as
 v
as
cu
lit
is
, 
ne
ur
al
gi
a,
 li
m
bi
c 
en
ce
ph
al
iti
s,
 a
cu
te
 
re
tin
al
 n
ec
ro
si
s
A
cu
te
 in
fe
ct
io
ns
 
w
ith
 s
om
et
im
es
 
se
ve
re
 s
eq
ue
la
e 
C
hr
on
ic
 m
en
in
-
go
en
ce
ph
al
iti
s 
in
 h
yp
og
am
m
a-
gl
ob
ul
in
em
ia
A
cu
te
 a
nd
 p
er
si
s-
te
nt
 in
fe
ct
io
ns
H
ig
h 
fa
ta
lit
y 
ra
te
Fl
ac
ci
d 
lim
b 
w
ea
k-
ne
ss
 in
va
ri
ab
ly
 
fa
ta
l o
ut
co
m
e
T
he
ra
py
N
o 
an
tiv
ir
al
s 
su
p-
po
rt
iv
e 
(I
V
IG
)
N
o 
an
tiv
ir
al
s 
su
p-
po
rt
iv
e 
(I
V
IG
)
N
o 
an
tiv
ir
al
s
su
pp
or
tiv
e
A
C
V
: H
SV
 a
nd
 
V
Z
V
G
C
V
 a
nd
 F
C
: C
M
V
 
an
d 
H
H
V
6
A
nt
iv
ir
al
s,
 e
ffi
ca
cy
 
ha
s 
no
t b
ee
n 
pr
ov
en
N
o 
an
tiv
ir
al
s
Su
pp
or
tiv
e 
(I
V
IG
)
M
V
: S
up
po
rt
iv
e 
(I
V
IG
)
M
uV
: C
or
tic
os
te
r-
oi
ds
N
iV
: h
M
A
b 
te
st
ed
 
in
 A
G
M
Su
pp
or
tiv
e 
(H
R
IG
)
V
ac
ci
ne
 th
er
ap
y
N
o 
an
tiv
ir
al
s
 Acta Neuropathol
1 3
patients varied greatly from <10 to 89 % [84]. CNS mani-
festations included meningeal irritation, confusion, hyper-
salivation with teeth-grinding, hallucinations, lock-in 
syndrome, choreiform movements, stupor and coma. Histo-
pathological examinations of the brain of fatal cases have 
revealed focal areas of necrosis associated with lymphocyte 
and macrophage infiltration [134] or mild congestion and 
edema of the white substance with mild hypoxic degenera-
tion of cerebral neurons [1]. However, further studies are 
required to identify the target cells of RVFV in the human 
CNS. Studies with nonhuman primates have provided 
important insights into RVFV-mediated neuropathogenesis. 
The most robust RVF nonhuman primate model makes use 
of common marmosets (Callithrix jacchus). In these mon-
keys, disease following peripheral infection manifests as 
either severe hepatic/hemorrhagic disease or encephalitis, 
whereas intranasal inoculation results in fatal encephalitis 
[119]. In a subsequent study, aerosol exposure of common 
marmosets but also of African green monkeys resulted in 
fatal encephalitis [53]. Primary pathology in the brain was 
associated with apoptosis of neurons in many regions of the 
brain with limited or no inflammatory response.
Toscana virus
The high seroprevalence of TOSV antibodies in the Medi-
terranean region with limited reports of clinical cases makes 
clear that TOSV infections are generally asymptomatic 
or manifest as a self-limited benign illness. This so-called 
“sandfly fever” has an incubation period of 3–6 days and may 
be associated with fever, myalgia, malaise and abnormalities 
in liver and hematological values. A substantial number of 
patients develop skin rash. Neurological manifestations may 
present with Kernig sign, nuchal rigidity, photophobia, con-
sciousness troubles, tremors, nystagmus and paresis. In some 
patients, the disease progresses from mild acute lymphocytic 
meningitis to meningoencephalitis or even encephalitis [29]. 
Although most patients recover within 7–10 days without 
sequelae, sporadic life-threatening atypical manifestations 
of TOSV infection have been reported [11]. Because TOSV 
infections are generally benign, very little is known about the 
pathogenesis of this virus in humans.
Flaviviridae
The family Flaviviridae consists of four genera; Hepaci-
virus which includes Hepatitis C virus, Pestivirus which 
includes Bovine viral diarrhea virus, Pegivirus which 
includes GB virus C (formally hepatitis G virus) and the 
genus Flavivirus. The Flavivirus genus includes viruses 
that are etiological agents of arboviral encephalitides and 
more systemic disease spectra including hemorrhagic 
fevers (e.g., dengue virus and yellow fever virus). Flavivi-
ruses are single-strand positive-sense RNA viruses.
Tick‑borne encephalitis virus
Tick-borne encephalitis virus (TBEV) is an important 
cause of CNS infection in Europe and Asia [77]. The dis-
ease is reported over a wide geographical range, spanning 
from Japan, throughout Asia into Europe (Fig. 3a). Thou-
sands of human cases of TBEV infection are reported 
annually in Europe and Asia. The virus is transmitted by 
the ticks Ixodes ricinus and Ixodes persulcatus in Europe, 
whereas Ixodes ovatus transmits the virus in Japan. Other 
virus transmission modes include consumption of infected 
unpasteurized milk or milk products from infected live-
stock, particularly goats. Phylogenetic analysis of several 
TBEV strains indicated the existence of three subtypes: (1) 
European (2) Siberian and (3) Far-Eastern subtype. The dif-
ferences between the subtypes constitute 5–6 % on amino 
acid level, but it is unclear whether these subtypes differ in 
virulence.
The incubation period of TBE depends on the route of 
infection, which ranges from 7 to 14 days after a tick bite 
and 3–5 days after alimentary transmission [109]. About 
70 % of TBEV infections are asymptomatic and only a few 
will develop mild flu-like disease. In general, the course of 
TBEV disease is mono- (up to 30 %) or biphasic (>70 %). 
The prodromal phase correlates with high viremia and is 
characterized by flu-like symptoms such as fever, head-
ache, myalgia, arthralgia, fatigue, anorexia and nausea. 
After 2–7 days, symptoms subside and patients may even 
recover. This brief recovery period is followed by the 
second disease phase where adult patients may develop 
meningitis (50 %), meningoencephalitis (40 %) or menin-
goencephalomyelitis (10 %) [65]. Most patients with the 
monophasic disease course develop more severe acute dis-
ease, presenting with meningitis or meningoencephalitis. A 
small fraction of patients with CNS involvement have sig-
nificant variation in heart rate or display signs of autonomic 
nervous system dysfunction. Chronic progressive TBE has 
been reported in Siberia and the Russian Far East, which 
is believed to be caused by the Siberian TBEV subtype. 
TBE may cause long-lasting impact in patients’ quality of 
life. The most frequently reported problems are cognitive 
disorders, neuropsychiatric complaints hearing loss, distur-
bances of vision, balance and coordination disorders and 
flaccid paresis or paralysis.
The frequency of abnormal electroencephalogram find-
ings appeared similar between patients with meningoen-
cephalitis (91 %) and meningoencephalomyelitis (96 %) 
[65]. MRI data suggest that patients with meningoencepha-
litis have lesions predominantly in the thalamus. Lesions 
have also been reported in the cerebellum, brainstem and 
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caudate nucleus. Immunohistochemical analysis dem-
onstrated TBEV protein expression in the spinal cord, 
brainstem, cerebellum and basal ganglia [42]. A similar 
widespread distribution of lesions and virus antigen can 
be detected in TBEV-infected dogs (Fig. 4). Analysis of 
human brain tissues has shown consistent detection of virus 
antigen in neurons in the anterior horn, Purkinje cells, den-
tate nucleus, tegmentum of medulla oblongata (e.g., infe-
rior olives, raphe nuclei and formatio reticularis), pontine 
nuclei and tegmentum of pons (L. coeruleus, N. dorsalis n. 
vagi and formatio reticularis) and caudate nucleus [42].
West Nile virus
West Nile virus (WNV) is transmitted between birds by 
Culex mosquitoes, in an enzootic cycle. Humans become 
infected when bitten by a mosquito carrying the virus. Since 
the first isolation of WNV in 1937 there have been sporadic 
cases and outbreaks worldwide. A number of large out-
breaks have occurred in North America since 1999 including 
a particularly large outbreak of encephalitis in 2002 with 
2942 cases [93] with additional smaller outbreaks occurring 
annually in Southern and Eastern Europe (Fig. 3b). On aver-
age 1 in 140 infected individuals will develop meningoen-
cephalitis, but the incidence is higher in the older popula-
tion (1 in 50 in >65 years compared to 1 in 300 in <65 years 
old). There are seven genetic lineages of the virus. Lineages 
1 and 2 are responsible for the major epidemics in humans 
and animals. It is thought that migratory birds contributed 
to the worldwide spread of WNV such as from Africa to 
Southern Europe. However, this hypothesis has been chal-
lenged with respect to the introduction of WNV to North 
America as it is unlikely that sick birds are capable of fly-
ing the required distances for this route of transmission to 
be viable. An alternative hypothesis is that mosquitoes were 
the cause of virus importation into North America.
The incubation period for WNV is normally 3–14 days. 
Patients with WN fever develop a sudden onset of an acute 
non-specific flu-like illness [123]. Some patients may also 
develop maculopapular rash, but myocarditis has also 
2015 season
2014 season
Earlier seasons
No reported cases
Not included
a b
c d
0 cases
1021 cases
123 cases
Fig. 3  Geographical distribution of selected flaviviruses capable 
of causing neurotropic infections in humans. a Cases of tick-borne 
encephalitis (demarcated within red-shaded zone) are distributed 
from central and eastern Europe across a wide band of Eurasia. b 
Distribution of cases of West Nile fever in the European region and 
Mediterranean basin in 2015 and previous seasons. c Gradient map 
showing cumulative cases of St. Louis encephalitis virus neuroin-
vasive disease in the USA from 1964 to 2010. d Cases of Japanese 
encephalitis virus (JEV) (red-shaded area) are diagnosed in many 
parts of South East Asia. a Adapted from [73]; b adapted from Euro-
pean Center for Disease Control and Prevention (ECDC) map of 
reported cases of West Nile fever, transmission season 2015 and pre-
vious transmission seasons; c adapted from Centers for Disease Con-
trol and Prevention (CDC) map; d adapted from CDC map of geo-
graphical distribution of Japanese encephalitis virus
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been described. Among individuals with CNS infection, 
presentation with either encephalitis or meningitis may be 
seen. However, the elderly more commonly present with 
encephalitis [25]. Severe generalized muscle weakness 
with a similar presentation to Guillain–Barré syndrome has 
been reported probably as the result of damage to the ante-
rior horn cells [123]. An acute flaccid paralysis (AFP) was 
also seen in patients during a few outbreaks [5]. Seizures 
were seen in approximately 30 % of patients during ear-
lier outbreaks but not during more recent ones. Mortality 
ranged from 2 to 14 % during the outbreak in North Amer-
ica with elderly people having the greatest risk of death 
[123]. Neurological disability was seen in just over half 
of patients at 1-year follow-up. There is no consensus on 
how WNV enters the CNS. Theories include direct infec-
tion of endothelial cells, infecting leukocytes which carry 
the virus into the CNS, crossing endothelial tight junctions, 
direct axonal retrograde transport from infected periph-
eral neurons. WNV infection is characterized by lympho-
cytic leptomeningitis, perivascular lymphocytic cuffs and 
lymphocytic polioencephalomyelitis. Numerous micro-
glial nodules and astrogliosis may occur in both the gray 
and white matter and involve the entire neuraxis. In the 
gray matter, microglial nodules are often associated with 
neuronophagia and neuronal loss. Several brain regions, 
including the cerebral cortex, hippocampus, cerebellum, 
brainstem and spinal cord are particularly affected [66, 
115]. It is still unclear as to how the virus causes neuronal 
injury, but most likely several mechanisms may contrib-
ute. While it has been suggested that apoptotic cell death 
of WNV-infected neurons is caspase-3 dependent [110], 
in vitro studies indicate that caspase-3-independent path-
ways also exist in WNV-associated cell death. In addition, 
infection of neurons with WNV results in the induction of 
several cytokines and chemokines, which promote leuko-
cyte invasion into the CNS and neuroinflammation [68]. 
Furthermore, there is evidence that WNV also infects glial 
cells, and that infection of astrocytes contributes to neu-
ronal death by releasing neurotoxic mediators [131]. MRI 
imaging may show atrophy or ischemic changes as well as 
meningeal enhancement [91]. T2-weighted images have 
also shown high signal intensities in the thalamus and other 
basal ganglia [121].
St. Louis encephalitis virus
St. Louis Encephalitis virus (SLEV) is found in the Americas 
with eight recognized lineages [106]. The virus is transmit-
ted by Culex mosquitoes to vertebrate hosts including birds 
and bats [7, 69]. SLEV-mediated encephalitis occurs follow-
ing an incubation period of 5–15 days and is seen in approxi-
mately 50 people per year in North America with 800 cases 
per 100,000 population occurring during epidemics which 
have a localized geographical distribution (Fig. 3c). Patients 
present with flu-like symptoms and in some cases diarrhea, 
nausea, vomiting, cough and sore throat may also occur. In 
individuals >60 years old, 90 % will develop encephalitis 
whereas this is only seen in 55 % of the younger patient. 
In the latter group the most common clinical manifestation 
is a reduction in conscious level. Cranial nerve palsies and 
urinary tract symptoms may also occur [124]. Seizures are 
a poor prognostic sign and can be seen children and more 
severe adult cases. One-third of patients have neuropsychiat-
ric sequelae including emotional disturbances, forgetfulness, 
tremor, unsteadiness and visual disturbances. Death occurs 
in approximately 7 % of patients with higher fatality rates 
in the elderly. Neuroimaging of patients infected with SLEV 
has consistently shown the presence of lesions in the substan-
tia nigra [21, 137], a finding which may explain the tremors 
that are often observed in symptomatic cases. Neuropathol-
ogy investigations have shown that pathological changes are 
largely restricted to the substantia nigra and cerebellum with 
neuronal degeneration, microglial activation and perivascu-
lar infiltrates of mononuclear cells observed in brain sections 
from these regions [104, 137]. Although SLEV antigen has 
been detected in the cell bodies of neurons [104], few stud-
ies have specifically examined the distribution of this virus in 
the CNS of fatal human cases.
Japanese encephalitis virus
Among the many arthropod-borne viruses that cause 
brain infections, Japanese encephalitis virus (JEV) is the 
most important, being responsible for large outbreaks 
across Asia. JEV is endemic in South and Southeast Asia 
(Fig. 3d). It is transmitted by Culex mosquitoes, most com-
monly Culex tritaeniorhynchus, which breed in rice paddy 
fields and other water sources. Virus transmission occurs 
in an enzootic (animal) cycle with a natural transmission 
cycle between birds and mosquitoes and an ‘amplifying 
cycle’ between pigs and mosquitoes. JEV can be transmit-
ted to humans via the bite of an infected mosquito which 
subsequently becomes the ‘dead-end’ host with no further 
transmission of the virus. It is estimated that <1 % infected 
individuals develop clinical features following an incuba-
tion period of 5–15 days, which may range from a flu-like 
illness, to severe and often fatal encephalitis in ~20 % of 
patients. Whereas children are more commonly affected, 
JEV-induced disease is also seen in adults, especially in 
areas where there is no pre-existing immunity. Seizures 
are a frequent clinical manifestation. However, AFP, extra-
pyramidal features and focal neurological deficits have 
also been described. Those with a reduced conscious level 
or abnormal tone, signs of brainstem herniation, raised 
intracranial pressure, seizures and fever tend to have a 
worse prognosis [120]. Disability is seen in up to 50 % of 
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survivors, often with a hemiparesis [102]. However, sei-
zures, behavioral problems and language impairment have 
also been described [49, 94].
Upon skin inoculation, the virus spreads hematogenously 
to the liver, kidneys, heart and spleen. The virus eventually 
crosses the blood–brain barrier (BBB) to enter the CNS. 
There is still uncertainty as to how the virus crosses the 
BBB. One theory is a ‘Trojan horse’ mechanism, whereby 
the virus is transported across the BBB via macrophages 
or monocytes. Other suggested theories include the passive 
transport of the virus across the endothelium, [35, 123] and 
immune-mediated damage to the BBB due to various proin-
flammatory cytokines. Compared to JEV survivors, cytokine 
levels in serum and CSF are increased in fatal cases [141]. 
High signal intensity in the thalamus, and other basal gan-
glia, midbrain, brainstem, and sometimes anterior spinal 
cord may be seen on T2-weighted MRI scans. Grossly the 
brain is swollen and congested. Lymphocytic infiltration 
is present throughout the brain, but particularly affected 
are the gray matter of the thalamus, substantia nigra, pons, 
medulla and spinal cord. Occasionally necrotizing encepha-
litis is encountered. Viral antigen is located in neurons of 
the cerebral cortex, thalamus, and brain stem. Glial scars 
may occur in substantia nigra and thalamus, and to a lesser 
extent in the cerebral cortex in long-term survivors [74]. 
There have been various suggestions as to why some people 
develop clinical manifestations whereas others do not. This 
may be attributed to the viral strain itself [23] or prior infec-
tion with other flaviviruses, including dengue virus, which 
may give a cross-protective immune response that may lead 
to more severe immunopathology [72, 123].
Herpesviridae
The Herpesviridae is an ancient family of enveloped dou-
ble-stranded DNA viruses which are widely disseminated 
in the animal world. Based on genomic and biological 
properties herpesviruses are divided into three subfami-
lies: α, β and γ viruses. Alpha-herpesviruses have a short 
reproductive cycle and establish latency in sensory gan-
glion neurons. Beta- and gamma-herpesviruses have a 
more restricted cell type range and replicate relatively slow 
in cell culture. Whereas beta-herpesviruses can establish 
latency in multiple cell types and organs (e.g., secretory 
glands, lymphocytes and kidneys), gamma-herpesviruses 
are restricted to specific lymphocyte subsets including B 
and T cells. Among the eight human herpesviruses (HHV), 
the alpha subfamily includes herpes simplex viruses type 1 
(HSV-1) and -2 (HSV-2) and varicella zoster virus (VZV). 
Human cytomegalovirus (HCMV) and the roseola viruses 
HHV-6 and -7 belong to the beta subfamily and the onco-
genic gamma subfamily consists of Epstein–Barr virus 
(EBV) and HHV-8. Primary HHV infection, commonly 
during early childhood via the orofacial route, is typically 
asymptomatic or mild (e.g., varicella and roseola infantum 
due to VZV and HHV-6, respectively) and does not warrant 
therapy [98].
A hallmark of herpesviruses is the establishment of life-
long latency in specific cell types and intermittent reacti-
vation leading to asymptomatic virus shedding or recru-
descent disease. Whereas innate immunity prevents virus 
dissemination during primary infection, adaptive immunity 
is pivotal to control latency. Consequently, severe HHV 
infections are more common in HHV-naïve adults and 
immunocompromised patients, but also associated with 
the anatomic site of infection. HHV infections of immune-
privileged sites, like the CNS and eye, may lead to poten-
tial sight- or even life-threatening diseases, respectively. 
Whereas HSV and VZV enter the CNS via the transax-
onal route, the remaining six HHVs spread to the brain 
via the hematogenous route within lymphocytes. The high 
prevalence of HHV infections worldwide argues for their 
Fig. 4  Neuropathology in the spinal cord of a 3-year-old dog 
(Bernese mountain dog) infected with tick-borne encephalitis virus 
(TBE). a Hematoxylin and eosin-stained section showing severe lym-
pho-histiocytic myelitis with perivascular predominantly lymphocytic 
cuffing (arrowheads). b Intralesional immunolabelling of TBE anti-
gen (arrows), detected using a rabbit polyclonal antibody
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potential etiopathogenic role in CNS diseases that can be 
monophasic, recrudescent or even chronic. The clinical 
and pathological features of the key HHVs associated with 
CNS dysfunction will be discussed.
Herpes simplex virus
HSV infection, either due to primary or reactivation of 
latent virus, is the most common cause of infectious 
encephalitis in humans [24]. The incubation period of 
HSV-1 following primary infection is 2–12 days whereas 
HSV-2 has an incubation period of 3–7 days in suscepti-
ble individuals. HSV-1 is responsible for up to 90 % of 
HSV encephalitis (HSE) cases, whereas HSV-2 infection 
being less common and more often presenting clinically 
as meningitis. Predisposing factors are diabetes mellitus, 
malignancies and conditions compromising the immune 
system. Interestingly, defects in the TLR3-interferon (IFN) 
and IFN-responsive pathways were shown to predispose to 
HSV encephalitis, particularly in children [150]. Therefore, 
TLR3-mediated immune response in the CNS may play 
an important role to control local HSV infection. Clini-
cally, HSE patients present with headache, fever and altera-
tion of mental status such as confusion, psychosis and also 
alteration of consciousness from somnolence to stupor and 
coma. With a predilection of HSV for the frontal and tem-
poral lobes, HSE patients may also present with seizures. 
In immunocompromised patients, HSE can be atypical and 
the disease may evolve rapidly and is life-threatening [81]. 
MRI scans of HSE patients often show hyperintensities on 
flair and T2-weighted images corresponding to cytotoxic 
edema in these areas (Fig. 5a–c).
Clinical outcomes are variable and largely depend on 
prompt initiation of antiviral therapy. Prior to use of the 
antiviral acyclovir (ACV), mortality of HSE patients was 
>70 % with a high rate of severe sequelae among survi-
vors. Sequelae are still found and include focal or gener-
alized seizures, personality changes, impaired memory 
Fig. 5  Magnetic resonance imaging and microscopic images of typi-
cal herpes simplex virus (HSV) encephalitis pathology in humans. 
Magnetic resonance imaging (MRI) of an acute HSV encephalitis 
case. a Swelling of the left temporal lobe (Fluid attenuation inver-
sion recovery, FLAIR). b Cortical cytotoxic edema typical for this 
neurotropic virus at the time of symptom onset (diffusion-weighted 
image, reduced apparent diffusion coefficient values not shown). c 
Parenchymal atrophy with residual gliosis 2 months later (FLAIR). 
Microscopic imaging of autopsy material of the basal ganglia (d, f) 
and the frontal lobe (e) of a patient with fulminant HSV encephali-
tis. d Immunohistochemically stained sections showing CD45-posi-
tive perivascular infiltrates. e Hematoxylin and eosin staining (H&E) 
showing additional intravascular thrombosis. f Several parenchymal 
hemorrhages in an H&E-stained brain section. a–c Images courtesy 
of Dr. Peter Raab (Department of Neuroradiology, Hannover Medi-
cal School, Hannover, Germany); d–f Images courtesy of Prof. Chris-
tian Hartmann (Department of Neuropathology, Hannover Medical 
School, Hannover, Germany)
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and/or cognition, motor deficits or aphasia. Predictors for 
a prolonged clinical course are the initial clinical presenta-
tion with coma and high lesion load on brain imaging, but 
not duration of antiviral therapy or age at onset of disease 
[128]. HSE is the most common fatal sporadic encephali-
tis. Necrotizing encephalitis is commonly localized to the 
orbitofrontal and temporal lobes, usually asymmetrical, but 
in most cases bilateral. Progressive temporal lobe edema 
can lead to uncal herniation [126]. HSV-1 infections can 
also cause a myelitis presenting as subacute or chronic 
monosegmental myelitis. Re-occurrence of HSV myelitis 
has been reported in up to 20 % of cases. Neonatal HSV 
infection is mainly caused by HSV-2, due to mother-to-
child transmission, with CNS involvement in about half of 
the infected infants [126]. Morphologically, acute ascend-
ing necrotizing myelitis occurs throughout the whole length 
of the spinal cord and involves both the gray and white mat-
ter [61]. Risk of long-term complications is high despite 
prompt ACV treatment. Sacral and lumbar radiculitis (Els-
berg syndrome) has also been associated with HSV-2 infec-
tions [36]. Recurrence of meningitis is common in HSV-2 
meningitis, and if large endothelial cells termed “Mollaret 
cells” are present in CSF analysis, the diagnosis of Mol-
laret’s meningitis is established. Pathology of HSV-induced 
CNS disease is largely due to viral cytopathic effect 
(Fig. 5d–f). HSV primarily infects neurons showing intra-
nuclear inclusions upon biopsy or autopsy. Phagocytosis of 
neurons by microglia, so-called neuronophagia, may occur. 
Recently, the occurrence of an autoimmune antibody-medi-
ated limbic encephalitis (NMDAR-encephalitis) has been 
associated with a history of HSV encephalitis [9]. HSE 
has also been described as a risk for subsequent potential 
blinding acute retinal necrosis (ARN) [135]. These com-
plications can occur independently of the immune status. 
Therefore, a close and careful clinical follow-up of HSE 
patients is recommended to early identify potentially life-
threatening and disabling subsequent diseases.
Varicella zoster virus
VZV, a neurotropic HHV that establishes life-long latency 
in almost all sensory ganglia, is the only HHV that causes 
two different diseases during primary (chickenpox: vari-
cella) and reactivation (shingles: herpes zoster) [98]. Vari-
cella is evident 14–16 days following primary VZV infec-
tion. VZV-induced neurological disease is rarely associated 
with chicken pox (varicella cerebellitis), but commonly 
after shingles involving the CNS (meningitis and myeli-
tis) and peripheral nervous system (cranial neuropathies 
and motor radiculopathies). Immunocompromised indi-
viduals are at increased risk of VZV-induced neurological 
disorders, particularly encephalitis. Cranial nerves, par-
ticular trigeminal and facial nerves, can also be affected 
and present as zoster ophthalmicus and facial nerve palsy, 
respectively [45]. The main complication is post-herpetic 
neuralgia (PHN), a neuropathic pain syndrome that may 
persist for months within the affected skin when shingles 
has already subsided. PHN pathology is most likely due to 
damage of the sensory nerve endings due to persistent VZV 
infection in the innervating ganglia and/or local inflamma-
tory responses. Prognosis of VZV-induced CNS disease is 
better than for HSV-induced CNS disease. But unlike HSV, 
VZV can infect vascular endothelial cells of large and small 
cerebral vessels leading to severe focal or multifocal brain 
ischemia, vessel wall necrosis with aneurysms and dissec-
tions [90]. A particular association of VZV vasculitis and 
zoster ophthalmicus has been reported [16]. Likewise HSV, 
VZV encephalitis can be followed by ARN (see above). 
In situ analyses on biopsy and autopsy specimens showed 
that VZV infection can be found in neurons, glial cells and 
infiltrating macrophages. In contrast to HSV, VZV infec-
tions in immunocompromised patients may induce multi-
focal encephalitis, ventriculitis, focal necrotizing myelitis, 
acute myeloradiculitis, cerebral infarcts and macrophage-
rich demyelinating “multiple sclerosis-like” periventricular 
cerebral and spinal cord lesions [89], probably due to an 
infection of oligodendrocytes. Intranuclear inclusions, viral 
antigen, and herpesvirus particles have been detected in 
ganglia of acutely infected patients [89]. The presence of 
infiltrating lymphocytes in affected nervous tissue indicates 
the additional involvement of the immune system in the 
pathology of VZV-induced neurological disorders.
Cytomegalovirus
Human cytomegalovirus (HCMV) has the largest genome 
amongst HHV and causes a variety of diseases, ranging 
from self-limiting to fatal [98] with clinical symptoms 
evident in some patients 3–12 weeks following infection. 
HCMV-induced neurological disorders, mainly in immu-
nosuppressed patients due to HCMV reactivation, include 
lumbosacral polyradiculomyelitis, longitudinal exten-
sive transverse myelitis and encephalitis [113]. Before the 
advent of ART, HCMV was the most frequent opportunis-
tic CNS infection in AIDS patients. HCMV neurological 
diseases, particularly encephalitis, are difficult to diagnose 
because of atypical clinical and neuroimaging features. 
Studies on HCMV-affected brain tissues implicate that the 
basal ganglia, diencephalon and brainstem are the major 
sites of HCMV infection. In situ analyses showed that 
the majority of cytomegalic cells originate from infected 
astrocytes, but HCMV has also been detected in neurons, 
astrocytes, oligodendrocytes, ependymal, choroid plexus 
and endothelial cells. HCMV neuropathology may pre-
sent as low-grade encephalitis with widespread microglial 
nodules often associated with few cytomegalic cells or as 
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necrotizing ventriculoencephalitis with abundant intranu-
clear inclusion bodies [74]. Congenital HCMV infection is 
a major public health concern that causes severe neurologi-
cal disease in infants leading to mental retardation, cerebral 
palsy and sensorineural hearing loss.
Epstein–Barr virus
Epstein–Barr virus is the causative agent of infectious mon-
onucleosis (IM) in naïve children and young adults, with 
clinical symptoms evident 4–6 weeks following infection. 
Less than 5 % of primary EBV infections cause CNS dis-
ease that present as meningitis, encephalitis, cerebellitis, 
cranial or peripheral neuropathies and polyradiculomyeli-
tis. Neurological involvement may occur shortly before, 
during or after IM or even in the absence thereof. Poly-
radiculomyelitis is most often as a post-infectious auto-
immune-mediated syndrome and patients respond well to 
steroid therapy often given in combination with antivirals 
[22]. EBV-related CNS diseases can be induced by primary 
infection or reactivation, but also associated with chronic 
EBV infection. In contrast to HSV and VZV, human EBV 
encephalitis lesions do not show presence of viral protein 
and nucleic acids questioning the direct neuropathic effect 
of the virus. Cerebellum and basal ganglia are reported 
to be equally involved during EBV infection, next to cer-
ebral hemisphere. Patients with isolated hemispheric gray 
or white matter involvement were reported to achieve good 
recovery while almost half of the patients with thalamic 
involvement developed sequelae. The highest mortality rate 
was among patients with isolated brain stem involvement 
[2]. Neuropathology is characterized by leptomeningeal 
mononuclear inflammatory infiltration, and perivascular 
cuffing, and occasional perivascular demyelination [30]. 
Current data suggest that EBV-induced CNS pathology is 
immune mediated.
Human herpesvirus 6
The two HHV-6 variants, HHV-6A and -B, have recently 
been re-classified as separate HHVs based on differ-
ences in epidemiology, cell tropism and disease associa-
tion [98]. Whereas no disease has been clearly linked to 
HHV-6A, HHV-6B can lead to exanthema subitum which 
has an incubation period of 1–2 weeks. Compared to the 
other lymphotropic HHVs, HHV6 infection also exhibits 
neurotropic characteristics. Neurological complications of 
primary HHV6 infection, mainly HHV-6B, in childhood 
include seizures, hemiplegia, meningoencephalitis and 
residual encephalopathy of which outcomes remain uncer-
tain [4]. Poor prognosis has been observed in children with 
exanthema subitum-associated encephalitis and febrile sta-
tus epilepticus. Incidentally HHV-6 reactivation in adult 
transplant patients, mainly bone marrow transplantation 
involving HHV-6B, may be the causative agent of myeli-
tis, meningitis and post-transplant acute limbic encephalitis 
[8]. Human neuropathology consists of perivascular mono-
nuclear cell cuffs located in hippocampus (limbic encepha-
litis), frontal and insular cortices associated with hemor-
rhages. In the temporal cortex, marked neuronal loss with 
gliosis and microglial nodules have been described. There 
are neither viral inclusions, inflammatory demyelination, 
parenchymatous necrosis nor meningeal inflammation. 
Immunochemically, HHV-6 antigen is located in nuclei of 
hippocampal neurons and in astrocytes [37].
Orthomyxoviridae
Neurological complications associated with human ortho-
myxovirus infections are most commonly associated with 
Influenza A viruses which are enveloped segmented nega-
tive-strand RNA viruses.
Influenza A viruses
Influenza A viruses are subtyped based on their surface gly-
coproteins hemagglutinin (HA) and neuraminidase (NA). 
Many host species have their own strains (e.g., waterbirds, 
humans, pigs, horses, dogs and bats), although cross-
species transmission occurs frequently. Humans can be 
infected with seasonal, pandemic and zoonotic influenza 
A viruses. Seasonal influenza A viruses (H3N2 and H1N1) 
circulate within the population, causing yearly epidemics. 
Pandemic influenza viruses are the result of cross-species 
transmission, after which they adapt to humans and spread 
worldwide. Four pandemics have occurred in the last cen-
tury, the 1918 H1N1 ‘Spanish flu’, the 1957 H2N2 ‘Asian 
flu’, the 1968 ‘Hong Kong flu’ and the 2009 H1N1 ‘Mexi-
can flu’ or ‘swine flu’. Zoonotic influenza virus infections 
in humans are the result of interspecies transmission, with-
out subsequent efficient transmission among humans. The 
best known examples are avian influenza H7N9 virus and 
highly pathogenic avian influenza (HPAI) H5N1 virus, 
which intermittently are transmitted from their poultry res-
ervoirs to humans.
The most common extra-respiratory complication of 
influenza is the development of CNS disease [71]. Influ-
enza virus infections have been linked to a wide array of 
neurological diseases, beginning with the 1918 ‘Spanish 
flu’ pandemic, which was associated with an outbreak of 
encephalitis lethargica and subsequently post-encepha-
litis parkinsonism years later [103]. Acute CNS diseases 
include febrile seizures, acute onset brain dysfunction, 
meningitis, encephalitis and encephalopathies. In addi-
tion, influenza viruses have been linked to the development 
of Guillan Barré syndrome, Kleine Levin syndrome and 
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transfer myelitis [46, 127]. Besides acute CNS manifesta-
tions, influenza viruses have also been associated with neu-
rodegenerative diseases [32]. Interestingly some strains are 
more frequently associated with CNS disease than others. 
Recent examples are the 2009 H1N1 pandemic virus and 
HPAI H5N1 virus [26, 46].
Maternal influenza has been associated with schizophre-
nia and bipolar disorder (BD) in the offspring. Early stud-
ies of prenatal influenza and schizophrenia were ecologic, 
associating influenza epidemics in populations to patients 
who would have been in utero during these epidemics 
[18]. However, these findings were not consistent in all 
studies. Consequently, studies with greater methodologic 
rigor were initiated. Unlike prior studies, the presence of 
influenza infection was determined from antibody-based 
assays of strains circulating in the population during the 
period of pregnancies in a large population-based birth 
cohort investigation known as the Child Health and Devel-
opment Study (CHDS) [17]. A nested case–control study 
conducted on this cohort demonstrated a threefold increase 
in risk of schizophrenia when influenza exposure occurred 
during the first half of pregnancy [17]. For influenza infec-
tion during the first trimester, the risk of schizophrenia was 
increased sevenfold. However, no increased risk of schizo-
phrenia for influenza exposure was observed during the 
second half of pregnancy, suggesting specificity to early to 
mid-pregnancy. Additional studies revealed that maternal 
influenza was associated with a greater than fourfold, sta-
tistically significant increased risk of BD [96]. The strong-
est effect size was found for BD with psychotic features, 
with an odds ratio of approximately sixfold. These findings 
were confirmed in similar assays on archived maternal sera, 
showing that maternal influenza was related to a greater 
than fivefold increased risk of BD with psychotic features 
[19]. There was, however, no increase in risk of BD without 
psychotic features following maternal influenza exposure. 
While these findings require replication in independent and 
larger cohorts, this work suggests that maternal influenza 
may be a risk factor for psychosis rather than for schizo-
phrenia or BD per se.
The pathogenesis of influenza virus-induced CNS 
disease in humans is largely unknown. Influenza virus-
associated CNS disease could be an indirect effect of the 
infection, due to systemic cytokines, a direct effect of virus 
entry into the CNS, or a combination of both [71]. Several 
studies have detected seasonal or pandemic influenza virus 
RNA or virus antigen within the CSF or cadaveric CNS 
tissues (Fig. 6) [111, 118, 132]. In addition, HPAI H5N1 
virus has been detected in cadaveric CNS tissues and CSF 
[26, 70]. The few studies that describe the histopathology 
of fatal influenza virus-associated CNS disease describe a 
diffuse cerebral congestion with edema, with an absence 
of infiltrating inflammatory cells (reviewed by [71]). CNS 
disease can also be associated with acute sub-arachnoid 
hemorrhage [118]. Only a few patients will develop acute 
necrotizing encephalopathy (ANE). This disease is charac-
terized by its fulminant and monophasic course, with mul-
tifocal brain lesions bilaterally predominantly in the thal-
amus, but also in brainstem, periventricular white matter, 
and cerebellar medulla, often associated with brain oedema 
[127].
The route of entry into the CNS is not completely under-
stood, but recent data indicate that influenza viruses may 
enter the CNS directly from the nasal cavity via the olfac-
tory nerve in humans [132]. Virus entry into the CNS via 
the olfactory nerve might also explain the case reports in 
which viruses were detected within the nasal cavity and the 
CNS, without evidence for initial severe LRT disease [26, 
118]. With regard to psychiatric disorders from prenatal 
influenza exposure, there are no studies in humans that have 
examined neuropathology at the in situ level. The patho-
mechanisms involved in the development of psychiatric 
Fig. 6  Central nervous system complications of influenza virus 
infections in humans. Detection of influenza virus antigen in neurons 
in the olfactory bulb of an H3N2 virus-infected immunocompromised 
child. a Hematoxylin and eosin-stained tissue section showing a lack 
of cellular infiltrates. b Immunohistochemcial detection of influenza 
virus antigen in neurons using an anti-nucleoprotein monoclonal anti-
body
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disorders remain enigmatic, but systemic cytokines are 
believed to be at least partially involved because studies of 
maternal immune activation in rodents have indicated simi-
lar behavioral and electrophysiological effects (for review, 
see [18]).
Paramyxoviridae
The family Paramyxoviridae is comprised of a broad group 
of enveloped single-stranded negative-sensed RNA viruses 
of animals and humans. In recent years, our understand-
ing of the true diversity of paramyxoviruses has under-
gone a renaissance with the discovery of novel paramyxo-
virus sequences in bats, rodents and birds [33]. However, 
the zoonotic potential of the viruses from which these 
sequences were derived is currently unknown. Only a small 
number of the known paramyxoviruses have been linked to 
the development of neurological disease in humans. Mea-
sles virus (MV), mumps virus (MuV), Hendra virus (HeV) 
and Nipah virus (NiV) virus are all capable of spreading to 
the human central nervous system (CNS) during systemic 
infection. This results in a wide spectrum of disease mani-
festations and clinical outcomes ranging from transient 
mild encephalitis or acute fatal encephalitis to long-term 
infections with severe neurological sequelae.
Measles virus
Measles virus is the prototype member of the genus morbil-
livirus and remains a leading cause of morbidity and mor-
tality in the developing world with an estimated 122,000 
deaths in 2012 [99]. Clinical signs of MV infection such 
as fever and a maculopapular rash are visible following an 
incubation period of approximately 14 days. The pathogen-
esis of measles is typically characterized by severe immu-
nosuppression and a pronounced epitheliotropism during 
later disease stages. The propensity of morbilliviruses such 
as measles virus (MV) or canine distemper virus (CDV) to 
spread to the central nervous system (CNS) of a susceptible 
host has been a long-recognized complication of the sys-
temic acute viral infection.
Acute demyelinating encephalomyelitis (ADME) typi-
cally occurs in 1:1000 measles patients. Few studies have 
definitively linked MV infection to this condition. Instead, 
ADME is considered an autoimmune disease in which an 
acute virus infection leads to inflammation of the brain 
with concomitant myelin damage. Acute lesions are dis-
seminated throughout the CNS and are characterised by 
perivenous infiltration and demyelination [82]. In most 
cases, patients recover with no complications but in <5 % 
cases disease is fatal. Measles inclusion body encepha-
litis (MIBE) occurs in immunosuppressed individuals 
3–6 months following an acute MV infection. These cases 
are typically associated with patients who are immunosup-
pressed due to HIV infection or who take immunosuppres-
sive drugs as a result of organ transplantation [3, 52]. Suba-
cute sclerosing panencephalitis (SSPE) occurs on average 
4–10 years following acute MV infection. The frequency of 
SSPE following MV infection <5 years of age is estimated 
to be approximately 1:1700 to 1:3300 [112]. The develop-
ment of clinical signs of encephalitis are commonly pre-
ceded or concomitant with ocular disturbances [39], but it 
is currently unknown if this occurs as a direct result of MV 
infection or indirectly via immunopathology. The neuropa-
thology of MIBE and SSPE are similar and both are char-
acterised by extensive infection of neurons and oligoden-
drocytes throughout the brain including the frontal cortex, 
occipital cortex, basal ganglia, thalamus pons, medulla and 
parietal cortex (Fig. 7a–c) [80]. Expression of MV antigen 
throughout neuronal processes is also commonly observed 
in the brain (Fig. 8b–d) [6]. Extensive perivascular infil-
trates occur throughout the brain and in the later stages of 
the infection, nerve cell degeneration and gliosis are com-
monly observed [86]. CDV has served in useful model sys-
tems in which morbillivirus CNS spread during natural and 
experimental infections could be readily assessed (Fig. 7d–
i). Analysis of MV sequences obtained from deceased 
MIBE and SSPE patients showed extensive mutations espe-
cially in genomic regions encoding determinants of virus 
assembly and/or cell-to-cell spread such as the matrix (M) 
protein or the cytoplasmic tail of the fusion (F) glycopro-
tein. It is assumed that these mutations facilitate the long-
term persistence and spread of the virus within the CNS.
Specific mechanisms of MV spread within the CNS are 
unknown but detailed pathological and ultrastructural stud-
ies of SSPE brain tissue have indicated that the mechanism 
of MV spread in the CNS is profoundly different from that 
observed in non-neural cells. MV infection of the CNS is 
characterised by a lack of virus budding and an absence 
of giant cell formation. This has led to the suggestion that 
measles virus spread between neural cells occurs through 
lateral cell–cell contacts in the absence of appreciable lev-
els of cell-to-cell fusion [6]. In spite of major advances 
in our understanding of how MV enters the body, spreads 
systemically and is released into the respiratory tract, our 
understanding of how wild-type non-tissue culture adapted 
MV transverses the synapse has stalled beyond observa-
tions made in in vivo model systems. While morbilliviruses 
clearly can spread trans-synaptically within the brain, many 
questions remain as to the underlying mechanism and con-
sequences of this for normal neuronal functioning (Fig. 8).
Mumps virus
Mumps virus (MuV) is a member of the genus Rubulavirus 
and causes a disease that was first accurately described by 
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Hippocrates in the first book of the Epidemics. Alongside 
the more common complication orchitis, the neurological 
complication of mumps was first noted by Robert Hamil-
ton in 1758. In spite of the ubiquitous nature of MuV as 
a common childhood disease in the pre-vaccine era, sur-
prisingly little is known about the pathogenesis of mumps. 
MuV infects a susceptible host via the respiratory tract 
and then spreads to local lymph nodes where amplifica-
tion of the virus results in systemic virus spread. Follow-
ing an incubation period of 7–21 days, the classical signs 
of mumps develop, such as bilateral swelling of the parotid 
glands (parotitis). MuV also infect the CNS and although 
estimates vary, it has been suggested that this can occur in 
up to 30 % of cases with approximately 1:6000 cases com-
plicated by more severe MuV encephalitis [108]. In the 
pre-vaccine era MuV was the leading cause of aseptic men-
ingitis which was typically mild, characterised by pleocy-
tosis of the CSF and resolved with few complications. This 
CNS complication commonly occurred in the absence of 
classical signs of MuV infection. In one large study, paro-
titis was only detected in 51 of 131 cases (37 %) of mumps 
meningitis [63]. The more severe mumps encephalitis can 
occur at the peak of acute infection (during parotitis) or up 
to 23 days later with death occurring in up to 20 % of these 
cases while 33 % of survivors show evidence of prolonged 
neurological sequela [108]. Pathologically, mumps enceph-
alitis resembles ADME and is characterised by extensive 
perivascular demyelination in the white matter of the cer-
ebral and cerebellar hemispheres, basal ganglia, midbrain, 
pons, medulla and spinal cord with areas of demyelina-
tion associated with the perivascular infiltration of immune 
cells, microglia and gliosis [31].
Henipaviruses
Nipah virus (NiV) and Hendra virus (HeV) virus, both 
members of the genus Henipavirus are zoonotic viruses 
which are capable of inducing severe neurological disease 
a b c
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Fig. 7  Morbillivirus infection of the CNS. Immunocytochemical 
detection of measles virus (MV) antigen using anti-nucleoprotein 
monoclonal antibody (a) or SSPE serum (b, c) in human brain sec-
tions from subacute sclerosing panencephalitis (SSPE) patients. d, e 
Hematoxylin and eosin-stained brain tissue sections from canine dis-
temper virus (CDV)-infected dogs. g–i Immunohistochemical detec-
tion of CDV-infected cells in dog brain tissue sections. a MV antigen 
(green) is present in neurons and associated processes in the occipital 
lobe of an SSPE case. b MV antigen (green) is restricted to oligoden-
drocytes and is not present in GFAP-positive astrocytes (red) in SSPE 
white matter. c MV-positive oligodendrocytes in close proximity to 
CD68-positive macrophages and GFAP-positive astrocytes (blue) in 
white matter from an SSPE case. d Cerebrum of a dog with CDV-
induced polioencephalitis with perivascular lymphocytic cuffs and 
diffuse gliosis. e Acute leukoencephalitis with severe demyelination 
in the medulla of a CDV-infected dog. f Chronic leukoencephalitis 
with severe demyelination (arrows) and perivascular lymphocytic 
cuffs is evident in the cerebellum of a CDV-infected dog. g Cerebrum 
of the same dog shown in panel d with CDV antigen evident in neu-
rons and neuronal processes. h Immunolabelling of CDV antigen in 
astrocytes and gitter cells in the medulla of the same dog shown in 
panel e. i Cerebellum of the same dog shown in panel f with CDV 
antigen present in astrocytes and gitter cells. a–c Images courtesy of 
Dr. Stephen McQuaid (Belfast Health and Social Care Trust, North-
ern Ireland)
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in humans. This occurs following virus spread via interme-
diate animal hosts from flying foxes of the genus Pteropus 
which serve as the reservoir host for these viruses. HeV 
was first detected in Queensland in 1994 following a dis-
ease outbreak in 21 racehorses and two humans and was 
rapidly identified as a novel paramyxovirus [114]. NiV 
was identified as the etiological agent responsible for a 
large outbreak of encephalitis among 229 pig farmers in 
Malaysia in 1998 [20]. Human NiV infections occurred 
as a direct result of virus spread from infected pigs. Sub-
sequent smaller outbreaks have occurred in India and in 
more recent years annual cases of NiV infection in Bang-
ladesh have been documented with infections occurring 
as a result of the consumption of NiV-contaminated date 
palm sap. In one case of HeV infection and twenty cases 
of NiV infection, relapsing encephalitis was observed a 
number of months after the initial acute infection resulting 
in severe neurological sequela with many parallels to the 
MV-induced neurological complication SSPE [6]. Prodro-
mal signs of henipavirus infection are general and include 
fever, lethargy and headache and occur following an incu-
bation period of 5–14 days. This rapidly progresses to neu-
rological signs of infection including limb weakness and 
segmental myoclonus. The neuropathology of henipavirus 
infection in humans is characterised by virus infection of 
neurons and disseminated small vessel vasculopathy which 
is particularly severe in the CNS. Virus infection of cere-
bral endothelial cells results in giant cell formation which 
may contribute to vasculitis and intravascular thrombosis 
in cerebral blood vessels [146, 147]. Such pathology is 
commonly associated with necrotic inflammatory lesions 
throughout the brain. In cases of relapsing henipavirus 
encephalitis, neuropathology involves extensive parenchy-
mal necrosis and oedema, gliosis and prominent infiltrates 
of macrophages and lymphocytes often with associated 
meningitis with virus-positive neurons and ependymal cells 
readily detected [145, 147]. However, in contrast to the 
acute CNS infection, vasculitis is not observed. Many ques-
tions relating to this late complication of henipavirus infec-
tion remain to be elucidated, especially any similarities to 
late complications of MV infection such as SSPE.
Picornaviridae
The family Picornaviridae is one of the largest virus fami-
lies consisting of small, non-enveloped single-stranded 
Open quesons relang to morbillivirus spread in the CNS
1. How are viral RNPs transported along axons?
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Fig. 8  Measles virus (MV) spread in the CNS. a Schematic dia-
grams illustrating the trans-synaptic spread of MV. (i) Neurons are 
initially infected by MV via an uncharacterized route of infection. 
Following virus entry MV is able to spread to connected uninfected 
neurons. (ii) Viral ribonucleoprotein (RNP) complexes consisting of 
viral genome encapsidated by nucleoprotein with associated phos-
phoprotein and polymerase are transported together with the fusion 
(F) and hemagluttinin (H) glycoproteins along axons to the synaptic 
termini. Axonal transport of viral RNPs is known to occur via both 
anterograde (AG) or retrograde (RG) axonal transport. (iii) Aggrega-
tion of viral RNPs and viral glycoproteins at the pre-synaptic termi-
nal. (iv) A number of questions relating to the mechanism and conse-
quences of MV spread in the CNS remain to be addressed. (b–d) MV 
transneuronal spread in human brain (b) and animal models (c, d). 
b Interconnected MV-infected neurons are present in brain sections 
from an SSPE patient (b), a rMV-infected Ifnarko-CD46Ge mouse 
(c). d A number of extended neuronal processes (arrows) connect 
infected neurons in the polymorph cell layer of the hippocampus of a 
C57/BL/6 mouse infected with the rodent-adapted MVCAM/RB strain. 
a Plate was composed using ©Motifolio.com Biomedical PowerPoint 
Toolkit Suite; b image courtesy of Dr. Stephen McQuaid (Belfast 
Health and Social Care Trust, Northern Ireland); c adapted from [76]; 
d adapted from [75]
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RNA viruses. The family is classified into 29 genera includ-
ing many human pathogens such as poliovirus (PV) and the 
non-polio enteroviruses (EVs) of the Enterovirus genus, 
human parechovirus (HPeV) and hepatitis A virus. Animal 
pathogens include foot-and-mouth disease virus and Theil-
er’s murine encephalomyelitis virus. Clinical symptoms 
caused by picornaviruses in humans vary greatly, ranging 
from the common cold to life-threatening infections such 
as encephalitis and myocarditis. Hereafter, picornaviruses 
that can cause neurological disease in humans will be 
discussed. CNS infections are most often caused by EVs 
and are estimated to cause 10–15 million infections in the 
United States with at least 30,000–50,000 hospitalizations 
per year, that are mainly due to aseptic meningitis [95]. 
Based on molecular and serological characteristics the EVs 
are classified into species EV-A, containing EV71 and sev-
eral Coxsackie A viruses (CV-A), species EV-B including 
coxsackie B viruses (CVB) 1–6 and all echoviruses, EV-C 
with the polioviruses (PVs) 1–3 and several CVAs, and 
EV-D containing EV-68 [129]. Following EVs, the second 
most frequent viral cause of CNS disease is HPeV [143], 
which belongs to the Parechovirus genus. The HPeV spe-
cies are only found in primates and now consists of 16 
types [12]. The disease spectrum is similar to that of EV 
infections, although HPeV infection is almost exclusively 
seen in children.
Enteroviruses
Enterovirus infections of the brain are caused by a variety 
of EV genotypes and occur most often in children under 
10 years of age. EVs account for more than 90 % of viral 
meningitis cases, while encephalitis only occurs in 3 % of 
neurological EV infections [107, 129]. Meningitis due to 
EVs is most frequently caused by echoviruses and CVB. 
Furthermore, CNS infections have been associated with 
AFP, disseminating myelitis and transverse myelitis [105]. 
The most global public health threat was attributed to PV 
causing AFP (poliomyelitis) often leading to permanent 
disabilities. Neuropathology of EV infection comprises 
lympho-histiocytic leptomeningitis with edema and pre-
dominantly perivascular lymphocytic cuffs in the neuro-
parenchyma with occasional neutrophils. In both, enceph-
alitis or encephalomyelitis, gliosis, microglial nodules, 
neuronophagia, neutrophilic infiltrates and necrosis may 
occur. Viral antigen is expressed in neurons, particularly of 
the brain stem and neuronal processes [88]. Neuropathol-
ogy varies considerably depending on the stage of the dis-
ease. In acute cases, hemorrhagic necrosis may be found 
grossly in the anterior horns of the spinal cord. In chronic 
cases, there is atrophy of the anterior spinal nerve roots 
and a reduced size of the corresponding anterior gray horn. 
Histological changes in the acute phase comprise diffuse 
lymphocytic spinal leptomeningitis and lymphocytic myeli-
tis of the anterior horns, occasionally associated with infil-
tration of neutrophils and occurrence of inclusion bodies in 
anterior horn cells. Subsequently, necrosis of motor neu-
rons occurs with activation of microglial cells and develop-
ment of microglial nodules. In fatal cases, these necrotic, 
reactive and inflammatory changes may obscure the normal 
architecture of the spinal cord. In chronic cases, the inflam-
matory infiltration decreases, neurophagia and microglial 
hyperplasia represents the most prominent finding. Addi-
tionally, plasma cellular infiltration occurs. In very late 
stages of the disease, loss of neurons in the anterior horn 
with focally extensive gliosis, loss of myelinated fibers in 
the affected region and atrophy of the corresponding ante-
rior spinal root nerves are seen [74]. Since the global polio 
vaccination roll-out in the 1950s and 1960s, poliomyelitis 
incidence is virtually eliminated with the exception of cir-
culating strains in Pakistan, Afghanistan and Nigeria [138]. 
Since then world surveillance studies as recommended by 
the World Health Organisation allowed for accurate moni-
toring of other causes of AFP.
Picornaviruses are transmitted via the oral–fecal route. 
Following transmission, the sites of primary replication are 
considered the respiratory and gastrointestinal tract. From 
there, the virus spreads via the blood to a variety of target 
organs. EVs can infect many different target cells including 
epithelial cells, neurons and cardiomyocytes [88]. There 
is increasing evidence that EVs are capable of infecting 
the CNS through distinct pathways. While enterovirus 71 
most likely spreads to the brain through the motor but not 
peripheral sensory or autonomic pathways [144], PV can 
enter the CNS either directly from the blood or by retro-
grade axonal transport when PV enters the neuromuscular 
junction [101].
The local immune response against picornavirus CNS 
infections is largely unknown and is mainly deducted from 
immunological evaluations in EV infection. Undoubtedly 
an adequate humoral response with release of neutraliz-
ing antibodies is crucial as a defence mechanism. Indeed, 
patients with antibody deficiencies, such as X-linked agam-
maglobulinemia, are at increased risk for chronic entero-
viral meningoencephalitis and long-term neurological 
symptoms [48]. Lack of specific maternal EV antibodies in 
neonates is a risk factor for the development of severe ill-
ness further emphasizing the need for a humoral immune 
response in EV infection [51]. In contrast to EV infections, 
no data are available that favor a protective role of neutral-
izing antibodies for HPeV CNS infections. Toll-like recep-
tor (TLR)-mediated cytokine expressions are increasingly 
being recognized as important pathogenic or protective 
mechanisms. For example, EVD68 inhibits TLR3-mediated 
immunity that triggers interferon-beta(IFN-β) expression 
and activation [149].
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Other EVs have emerged more recently. From the late 
1990s, EV71 has caused massive outbreaks in the Asian 
Pacific region associated with brain stem encephalitis caus-
ing hundreds of deaths mainly in children [122]. In addition, 
EV71 and CV-A were linked to neurological disease such 
as Guillain–Barré syndrome and myelitis (including trans-
verse myelitis). EVD68 was first isolated from children with 
lower respiratory tract infections in 1967, but as the inci-
dence of AFP also occurred during EVD68 outbreaks [48], 
the association with neurologic disease was further investi-
gated. In clinical practice, neurological symptoms such as 
vomiting, irritability, and nuchal rigidity in young children 
should trigger clinicians to focus on diagnosing EV infec-
tions. Beside CNS-specific symptoms, EV-induced clini-
cal symptoms are aspecific including poor feeding, general 
malaise and low-grade fever. Some EVs, however, have 
strong unique clinical associations. For example, EV71 has 
been associated with neurogenic pulmonary edema [88].
Human Parechoviruses
Human Parechovirus infections are usually associated with 
(upper) respiratory tract and gastrointestinal infections in 
young children, although incidentally severe neurologic 
disease such as flaccid paralysis, meningitis, encephali-
tis and encephalomyelitis has been reported. The clini-
cal picture is clearly different from the other HPeV infec-
tions. HPeV3 infection in adults is often asymptomatic or 
elicits minor disease such as myalgia [83], whereas severe 
HPeV3 disease in immunocompromised adults is increas-
ingly acknowledged [78]. Children infected with HPeV3 
are usually younger than 3 months of age and often pre-
sent with fever, feeding problems and irritability as signs 
of CNS involvement [12]. In neonatal encephalitis, HPeV3 
infection shows specific white matter involvement extend-
ing into the subcortical white matter involving entire tracts 
of fibers. A recent study was able to demonstrate HPeV3 
infection of meningothelial and vascular smooth mus-
cle cells in two neonates with fatal leukoencephalopathy, 
suggesting that dysfunction of infected blood vasculature 
may have primarily caused the periventricular white mat-
ter lesions in these patients [13]. Severity of white matter 
lesions is predictive of neurodevelopmental outcomes in 
these children [136]. HPeV1 uses members of the integrin 
family as cellular receptor(s) [64]; however, the HPeV3 
receptor is not yet identified and will likely be different. 
Differential receptor expression on target cells further 
defines tissue tropism. The transport of the virus from its 
primary replication sites to the brain has not been fully elu-
cidated, and may be realized by crossing the blood–brain 
barrier or via retrograde transaxonal transport [105, 129]. 
The pathogenicity and tropism of HPeVs has not been yet 
been fully established yet.
Rhabdoviridae
The family Rhabdoviridae comprises 11 genera, of which 
viruses within the genus Lyssavirus and Vesiculovirus are 
of medical and veterinary importance. The genus Lys-
savirus contains seven genotypes: rabies virus (RABV; 
genotype 1), Lagos bat virus (genotype 2), Mokola virus 
(genotype 3), Duvenhage virus (genotype 4), European 
Bat lyssaviruses type 1 and 2 (genotypes 5 and 6), and 
Australian bat lyssavirus (genotype 7). RABV is prevalent 
throughout the world with only few countries being rabies 
free. The virus infects mammalian species, most frequently 
carnivores and bats. Genotypes 2 through 7 are geographi-
cally restricted and have bat reservoirs. The genus Vesicu-
lovirus contains the vesicular stomatitis virus (VSV), an 
arthropod-borne virus that infects primarily rodents, swine, 
horses, and cattle. Humans only experience mild symptoms 
upon VSV infection. Currently there is no effective treat-
ment for clinical rabies and a better understanding of the 
pathogenesis is needed to develop better post-exposure 
treatment regimens and curative treatments for this invari-
ably lethal disease.
Rabies virus
Rabies is a neurological disease characterized by a fatal 
encephalitis, caused by RABV or one of the other lyssa-
viruses, which are usually transmitted through a bite or 
scratch of infected carnivores (terrestrial rabies) or bats 
(bat rabies). Rabies presents as either furious or paralytic 
rabies (67 and 33 %, respectively). Approximately 55,000 
to 60,000 people are reported to die annually as a result of 
rabies. Clinical manifestations of terrestrial and bat rabies 
are different [130]. This difference may be associated with 
differences between strains of RABV from terrestrial carni-
vores and bats, as well as the route of viral spread. Patients 
infected with RABV typically go through different stages 
of disease: the incubation, prodromal, neurological, and 
comatose stages and finally death. The incubation time of 
rabies is on average 2 months, but can vary from weeks to 
up to 1 year. In the prodromal phase, patients may expe-
rience mild and non-specific symptoms such as fever and 
gastrointestinal discomfort. In the neurological phase, furi-
ous rabies patients may develop paresthesia at the site of 
exposure, anxiety or agitation, dysautonomia (autonomic 
dysfunction) including inspiratory spasms, hypersalivation 
hydrophobia, sometimes in combination with aerophobia 
and fluctuating mental state. Later in the disease, patients 
may develop altered levels of consciousness, before they 
eventually enter into the comatose stage. Patients with furi-
ous rabies who enter the comatose stage may develop flac-
cid limb weakness, which could be misinterpreted as para-
lytic rabies. The last stage of the disease is a painful and 
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excruciating death. The paralytic form of rabies is rather 
characterized by progressive weakness and paralysis, with 
absence of many of the symptoms seen in the neurologic 
phase of furious rabies. Paralytic rabies is often misdiag-
nosed as Guillain–Barré syndrome (GBS), autoimmune 
disease or stroke. In general, weakness is the initial man-
ifestation in paralytic rabies and GBS. Paralytic rabies is 
more often seen in bat rabies and especially in patients who 
received post-exposure vaccination [44]. The muscle weak-
ness observed in paralytic rabies is likely caused by periph-
eral nerve dysfunction and/or the involvement of anterior 
horn cells or of motor nerve fibers. Bat-associated RABV 
infection usually presents with myoclonus, hemichorea and 
symptoms related to a one-side deficiency of the sympa-
thetic trunk activity, such as a weak, droopy eyelid, con-
stricted pupil, decreased sweating and in some cases an 
inset eyeball [54, 130]. The presence of myoedema and uri-
nary incontinence in patients differentiate paralytic rabies 
from GBS.
It is generally believed that low titer virus exposure will 
first lead to one or more rounds of replication in muscle 
cells before motor neurons at the neuromuscular junctions 
are infected. In contrast, exposure to a high virus titer, leads 
to direct infection of motor neurons whereas sensory neu-
rons are probably not infected. Nevertheless, several cases 
of rabies following skin lesions have been reported [47, 
133], although it is not clear whether sensory neurons were 
infected in those cases. It is possible that different genotype 
1 lyssaviruses have differential tropism for sensory neu-
rons and epidermal cells [85]. Following infection through 
a bite of an infected animal, the virus infects motor neu-
rons and reaches the spinal cord by retrograde transaxonal 
transport, where it infects interneurons and neurons of the 
dorsal root ganglia (DRG) innervating the bitten extremity. 
Small DRG neurons that target higher order interneurons in 
the dorsal horn are subsequently infected [54], eventually 
leading to infection of the brain stem and the limbic sys-
tem. Once in the CNS, RABV spreads throughout the brain 
and migrates back to the periphery probably via the DRG 
late in the infection process by anterograde transaxonal 
transport [87]. Late in the disease course the virus can be 
found in skin, salivary glands, heart, kidney and cornea. 
However, it is unclear if the virus is only present in the 
nerve endings or also in the parenchyma of the different 
organs. Consequently, virus tropism for salivary glands and 
lacrimal glands remains unexplained, as infectious RABV 
can be recovered from the saliva, tears and tracheobron-
chial secretions.
Air-borne infection with RABV or infection via trans-
plantation of infected tissues or organs represents uncom-
mon modes of transmission [125, 140]. A classical event 
of multiple organ transplantation-related rabies occurred 
in Germany in 2010. A RABV-infected dog in India bit a 
26-year-old female drug user. Unfortunately, the infection 
was interpreted as toxic psychosis 8 weeks after return to 
Germany. Her lungs, kidneys, pancreas, liver and cornea 
were transplanted into six different patients [142]. The 
46-year-old female lung recipient died within 7 weeks 
after showing neurological signs. Histologically, a multi-
focal mild non-suppurative menigoencephalitis with cyto-
plasmic eosinophilic inclusion bodies (Negri bodies) in 
neurons was present in different brain regions (Fig. 9a). 
Rabies viral antigen was detected by immunohistochemi-
cal staining in neurons of various brain regions (Fig. 9b) 
and the spinal cord. Virus was localized in axons and den-
drites, in numerous peripheral nerves of the transplanted 
lung as well as in nerves of the thyroid gland, kidneys, 
pancreas, salivary gland and in ganglia of the intestinal 
wall. Electron microscopy confirmed RABV in the brain. 
In general, RABV is found in several areas of the brain of 
patients with furious rabies, including cerebellum, brain-
stem, the limbic system and the cortex. Systematic studies 
Fig. 9  Characterisation of fatal rabies encephalitis in the hippocam-
pus of a 46-year-old human who received a lung transplant from a 
rabies virus-infected donor. a Hematoxylin and eosin staining show-
ing eosinophilic cytoplasmic inclusion bodies (Negri bodies) in the 
perikaryon of neurons (arrows). b Immunohistochemical labeling 
using polyclonal goat anti-rabies antisera of rabies viral antigen in the 
perikaryon of neurons (arrows)
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of RABV distribution in brains of humans who died with 
furious or paralytic rabies are lacking. There is evidence 
from infected dogs that viral protein expression in the 
brain differs between furious and paralytic rabies, in that 
more antigen is detected in the cerebrum of furious cases, 
whereas brainstem inflammation is more pronounced in 
paralytic cases [116].
Conclusion
Infections with a wide range of viruses from different 
virus families may cause immediate or delayed neuro-
pathological changes and neurological manifestations in 
humans and animals worldwide. The ability of a virus to 
cause an acute or more long-term infection of the CNS 
is undoubtedly due to a complex milieu of many factors 
including host genetics, specific interaction with the host 
immune system, capacity to spread rapidly to immuno-
privileged sites such as the brain and unique modali-
ties of cell-to-cell spread within the CNS. Collectively 
these interactions determine the speed and severity of 
the disease course. A better understanding of the molec-
ular, epidemiological and biological characteristics of 
these infections and in particular of the mechanisms 
that underlie neuropathological or immune-pathological 
alterations associated with their clinical manifestations 
are expected to provide tools for the development of 
more effective intervention strategies and treatment regi-
mens. This will be of critical importance in the event of 
future novel neurotropic infections caused by zoonotic 
viruses.
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